Back to Search
STEVEN KYLE, PHARMD
PHARMD
Pharmacist
NPI: 1801085196Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
RPH48739(CA)
Research & Publications (20)
Exploiting the Achilles heel of cancer: the therapeutic potential of poly(ADP-ribose) polymerase inhibitors in BRCA2-defective cancer.
PMID 18820000·Br J Radiol·2008
7-preclinical
Physical activity and risk of upper respiratory tract infections.
PMID 14672089·Clin J Sport Med·2003
8-other
Cerebral correlates of heart rate variations during a spontaneous panic attack in the fMRI scanner.
PMID 19657971·Neurocase·2009
5-case
Production of self-assembling biomaterials for tissue engineering.
PMID 19497631·Trends Biotechnol·2009
6-review
Sentinel lymph node biopsy experience in Taranaki: a prospective audit in a provincial New Zealand hospital.
PMID 19305449·N Z Med J·2009
8-other
Paediatric surgery carried out by general surgeons: a rural New Zealand experience.
PMID 18796023·ANZ J Surg·2008
8-other
Differences in depressive symptom profile between males and females.
PMID 17980438·J Affect Disord·2008
8-other
Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial.
PMID 17363489·Mol Cancer Ther·2007
7-preclinical
Prospective audit of colorectal resections in a peripheral public hospital.
PMID 16922905·ANZ J Surg·2006
8-other
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.
PMID 15829966·Nature·2005
7-preclinical
Guideline for anti-TNF-alpha therapy in psoriatic arthritis.
PMID 15695305·Rheumatology (Oxford)·2005
6-review
Mycobacterium chelonae infection successfully treated with oral clarithromycin and linezolid.
PMID 15541095·Br J Dermatol·2004
5-case
Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymerase.
PMID 15481984·J Med Chem·2004
8-other
Efficacy of bracing the lower limbs and ambulation training in children with myelomeningocele.
PMID 15132267·Dev Med Child Neurol·2004
6-review
Potentiation of cytotoxic drug activity in human tumour cell lines, by amine-substituted 2-arylbenzimidazole-4-carboxamide PARP-1 inhibitors.
PMID 15109627·Bioorg Med Chem Lett·2004
7-preclinical
Novel poly(ADP-ribose) polymerase-1 inhibitor, AG14361, restores sensitivity to temozolomide in mismatch repair-deficient cells.
PMID 14871963·Clin Cancer Res·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2315 CAPITOL AVE STE 1020
SACRAMENTO, CA 95816 - Phone
- (916) 436-1401
Quick Facts
- NPI
- 1801085196
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile